Funding for this research was provided by:
Text and Data Mining valid from 2020-03-13
Received: 11 October 2019
Accepted: 5 March 2020
First Online: 13 March 2020
Ethics approval and consent to participate
: This study was approved by the Ethics Committee of the “P. & A. Kyriakou” Children’s Hospital, #91, 24-2-2017. The informed consent included information regarding the compound, its use and that it is accepted by the National Drug Organization.
: Not applicable.
: DIM has received honoraria from Gerolymatos Int.S.A. MVD and JL have no declared conflicts of interest. KA is a consultant/scientific advisory board member for Gerolymatos Int.S.A. BS-P has no declared conflicts of interest. JAF is the leading author of CARAT10 and CARATKids and is a member of the MASK/Allergy Diary research group. JB is the Director of the Fondation MCVIA-LR that owns the Allergy Diary mobile application. He reports personal and/or consultancy fees and/or honoraria for meeting lectures or is member of advisory boards of Chiesi, Cipla, Hikma, Menarini, Mundipharma, Mylan, Novartis, Sanofi-Aventis, Takeda, Teva, Uriach and has shares in Kyomed, all outside the submitted work. NGP has received honoraria from AZ, BI, GSK, Medscape, HAL Allergy B.V., Novartis Pharma AG, Menarini, Mylan, and Danone Nutricia Research.